Publications

Ovarian Cancer

Wu Q, Lothe RA, Ahlquist T, Silins I, Tropé CG, Micci F, Nesland JM, Suo Z, Lind GE.

DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets.

Mol Cancer. 2007;6:45.

Tam KF, Liu VW, Liu SS, Tsang PC, Cheung AN, Yip AM, Ngan HY.

Methylation profile in benign, borderline and malignant ovarian tumors.

J Cancer Res Clin Oncol. 2007;133(5):331-41. Epub 2006 Dec 20.

Wei SH, Balch C, Paik HH, Kim YS, Baldwin RL, Liyanarachchi S, Li L, Wang Z, Wan JC, Davuluri RV, Karlan BY, Gifford G, Brown R, Kim S, Huang TH, Nephew KP.

Prognostic DNA methylation biomarkers in ovarian cancer.

Clin Cancer Res. 2006 1;12(9):2788-94.

Chiang JW, Karlan BY, Cass L, Baldwin RL.

BRCA1 promoter methylation predicts adverse ovarian cancer prognosis.

Gynecol Oncol. 2006;101(3):403-10.

Additional References

Makarla PB, Saboorian MH, Ashfaq R, Toyooka KO, Toyooka S, Minna JD, Gazdar AF, Schorge JO.
Promoter hypermethylation profile of ovarian epithelial neoplasms.
Clin Cancer Res. 2005;11(15):5365-9.

Ibanez de Caceres I, Battagli C, Esteller M, Herman JG, Dulaimi E, Edelson MI, Bergman C, Ehya H, Eisenberg BL, Cairns P.
Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients.
Cancer Res. 2004;64(18):6476-81

Katsaros D, Cho W, Singal R, Fracchioli S, Rigault De La Longrais IA, Arisio R, Massobrio M, Smith M, Zheng W, Glass J, Yu
Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancer.
Gynecol Oncol. 2004;94(3):685-92.

 

Wiley A, Katsaros D, Chen H, Rigault de la Longrais IA, Beeghly A, Puopolo M, Singal R, Zhang Y, Amoako A, Zelterman D, Yu H.
Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential.
Cancer. 2006; [Epub ahead of print]

Strathdee G, Vass JK, Oien KA, Siddiqui N, Curto-Garcia J, Brown R.
Demethylation of the MCJ gene in stage III/IV epithelial ovarian cancer and response to chemotherapy.
Gynecol Oncol. 2005;97(3):898-903.

Rathi A, Virmani AK, Schorge JO, Elias KJ, Maruyama R, Minna JD, Mok SC, Girard L, Fishman DA, Gazdar AF.
Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women.
Clin Cancer Res. 2002;8(11):3324-31.